Damien Caillet Portillo, Xavier Puéchal, Maëva Masson, Marie Kostine, Alexia Michaut, André Ramon, Daniel Wendling, Nathalie Costedoat-Chalumeau, Pascal Richette, Hubert Marotte, Justine Vix-Portet, Jean-Jacques Dubost, Sébastien Ottaviani, Gaël Mouterde, Anne Grasland, Aline Frazier, Vincent Germain, Fabienne Coury, Anne Tournadre, Martin Soubrier, Laurent Cavalie, Pauline Brevet, Laurent Zabraniecki, Bénédicte Jamard, Guillaume Couture, Laurent Arnaud, Christophe Richez, Yannick Degboé, Adeline Ruyssen-Witrand, Arnaud Constantin
OBJECTIVES: Tropheryma whipplei infection can manifest as inflammatory joint symptoms, which can lead to misdiagnosis of inflammatory rheumatic disease and the use of disease-modifying antirheumatic drugs. We investigated the impact of diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease. METHODS: We initiated a registry including patients with disease-modifying antirheumatic drugs-treated inflammatory rheumatic disease who were subsequently diagnosed with Tropheryma whipplei infection...
February 2024: Journal of Infection